[Effectiveness of intraperitoneal chemotherapy in combined treatment of gastric cancer].
The schemes of postoperative intraperitoneal chemotherapy and polychemotherapy of gastric cancer have been developed. In their use, the 2-year survival of the patients increased by 17.2%, in absence of regional metastases--by 40%, in their presence--by 16.1%, in endophytic growth of tumors--by 14.3%, in exophytic growth--by 11.8% when compared with the results of surgical treatment alone.